BALTIMORE, Md.—The novel therapeutic agent PA65020 (enteric-coated aspirin plus immediate-release omeprazole) significantly reduced gastrointestinal mucosal damage after 28 days of treatment compared ...
SPARTA, N.J., Nov. 04, 2021 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), is a specialty pharmaceutical company focused on its clinically-validated and patent-protected ...
Q. I love the down-to-earth drug information in your columns, with the pros and cons of various medications. After reading about the “new” wonder drug aspirin, I started taking an enteric-coated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback